scispace - formally typeset
H

Hong Li

Researcher at Yale University

Publications -  10
Citations -  401

Hong Li is an academic researcher from Yale University. The author has contributed to research in topics: Retinal ganglion & Population. The author has an hindex of 7, co-authored 9 publications receiving 286 citations.

Papers
More filters
Journal ArticleDOI

Association of Human Papillomavirus Status at Head and Neck Carcinoma Subsites With Overall Survival.

TL;DR: Human papillomavirus positivity was associated with improved survival in 4 subsites (oropharynx, hypopharynX, oral cavity, and larynx), and the largest survival difference was noted in the oropharynx and hypopharyx subsites.
Journal ArticleDOI

A PEDF N-terminal peptide protects the retina from ischemic injury when delivered in PLGA nanospheres.

TL;DR: PLGA-PEDF(82-121) offers greater protection to the retina suggesting that this peptide and the method of delivering therapeutically active drugs have potential clinical advantages for longer-term treatments of retinal diseases.
Journal ArticleDOI

Ex vivo pretreatment of human vessels with siRNA nanoparticles provides protein silencing in endothelial cells

TL;DR: It is shown that a single transfection of small interfering RNA targeting class II transactivator attenuates major histocompatibility complex class II expression on endothelial cells for at least 4 to 6 weeks after transplantation into immunodeficient mouse hosts, suggesting that poly(amine-co-ester) nanoparticles, potentially administered during ex vivo normothermic machine perfusion of human organs, could be used to modify endothelial Cells with a sustained effect after transplanting.
Journal ArticleDOI

STAT3 activation protects retinal ganglion cell layer neurons in response to stress

TL;DR: Infection with constitutively active STAT3 gave substantial protection when compared to the other constructs, and persistent activation of STAT3 by neurotrophic factors provides strong neuroprotection and will be an effective strategy in a number of chronic retinal diseases.
Journal ArticleDOI

Current and future disease progression of the chronic HCV population in the United States.

TL;DR: It is found that the total diagnosed chronic HCV population grew from 983,000 to 1.19 million in 2007–2009, with patients born from 1945–1964 accounting for 75.0% of all patients, 83% of AdvLD patients, and 79.2% of costs in 2009, indicating that HCV is primarily a disease of the “baby boomer” population.